GVR Report cover Burn Care Market Size, Share & Trends Report

Burn Care Market Size, Share & Trends Analysis Report By Product (Advanced Dressings, Biologics), By Depth of Burn (Minor, Partial Thickness), By Cause, By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-1-68038-850-3
  • Number of Pages: 140
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Report Overview

The global burn care market size was valued at USD 2.3 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.1% from 2022 to 2030. The demand for burn care products is on a rise owing to the rising incidence of burns, high demand for skin grafts, growing awareness regarding treatment options, and increasing technological advancements. Increasing awareness level among the people regarding various treatment options related to burn care is a key factor driving the market over the forecast period. The market is also gaining pace owing to the rising willingness among people to spend more and opt for new advanced burn care products.

U.S. burn care market size, by product, 2020 - 2030 (USD Billion)

The different treatment options for burn care include advanced dressings, traditional burn care products, biologics, and others. Advanced dressings include alginate dressings, hydrogel dressings, foam dressings, hydrocolloid dressings, collagen dressings, and others. Biologics including skin grafts and other traditional burn care products are also widely used. Owing to the presence of a wide array of such products in the market, the awareness level about these products is increasing among patients as well as healthcare professionals such as surgeons, physicians, and nurses. 

Post pandemic, the market is expected to recover at a rapid pace. The demand for burn care products used in home settings has increased eventually, to avoid visiting healthcare facilities. In addition, many patients have adopted online counseling for their health-related concerns. Key players in the market are launching products to provide online counseling and guidance to patients who cannot visit healthcare facilities for treatment. For instance, Healogics, Inc. launched the Healogics Telehealth Program, telehealth for wound care patients, during the COVID-19 crisis. It provides patients access to continued wound care and various options of wound care treatments to help limit the potential need for hospitalization or emergency room admission. Some wound care centers are engaged in supporting hospitals with COVID-19 treatment. Therefore, this program allows patients at these centers to receive continuous wound care. 

In addition, many doctors and clinicians are also using telehealth to treat their patients and provide knowledge regarding the use of advanced wound care products. The following are the latest insights published on MobiHealthNews (HIMSS) in December 2021: VeCare, a point-of-care wound evaluation platform developed by researchers from the National University of Singapore, consists of a smart bandage with sensors and a smartphone app for remote wound monitoring. This wearable device can detect factors of chronic wounds within 15 minutes. Such factors are further contributing to the market growth.

Favorable government initiatives such as reimbursement policies which cover almost 70.00-100.00% of the treatment cost urge the patients to opt for advanced burn care treatment. The presence of government organizations such as the World Health Organization (WHO) and non-profit organizations like the American Burn Association (ABA) also contribute to increasing awareness levels. The WHO has been collaboratively working with The International Society for Burn Injuries and other such organizations to develop strategies to improve burn care and prevent burn injuries globally.

Furthermore, the presence of non-profit organizations such as the British Burn Association and the Canadian Association of Burn Nurses, which aim towards providing and propagating knowledge on the best treatment and rehabilitation following a burn injury, is also increasing the awareness levels regarding burn care and treatment among the people. The rising demand for skin grafts is yet another major factor boosting the market growth. The recent trend of burn care and treatment has shifted to a more comprehensive approach that not only focuses on recovery from burn injury but also on improvement in long-term function and form of the healed injury and quality of life.

Skin grafts are majorly used on partial and full-thickness burns and have an important role in the treatment of burn injuries. Skin grafts can be biological or synthetic in nature. Owing to this trend, the demand for use of skin grafts and other skin substitutes in the treatment and management of acute burns has increased and is rising at a constant pace. In addition, key players operating in the market are focusing on planned initiatives like the launch of new products, and mergers and acquisitions are helping the market grow. For instance, in June 2021, Mallinckrodt Pharmaceuticals received FDA approval for its engineered skin product, StrataGraft, for the treatment of serious thermal burns.

Product Insights

The advanced dressing segment dominated the market and accounted for the largest revenue share of 43.6% in 2021 owing to the wide product range and extensive application in wound management. Advanced wound dressings include collagen, alginate, hydrocolloid, hydrogel dressings, foam, and film dressings as well as other advanced dressing products. In addition, the development of advanced products such as ConvaTec’s FoamLite foam dressing, which can be used for a range of low to heavy exuding wounds, is further contributing to the growth of this segment.

The biologics segment is anticipated to witness the fastest growth over the forecast period owing to the introduction of new products and extensive R&D in this field. Biologics involve the application of active biological agents and molecules, such as monoterpenes (sulbogin, thymol, and sericin) that are antioxidants, antimicrobials, and anti-inflammatory in nature. Biologic dressings also include skin grafts (allografts, xenografts, autografts, or cadaveric human skin) and tissue-engineered products designed to replace the function and form of skin, either temporarily or permanently. The major advantage of biologic skin dressings or skin grafts is that skin is readily available from the patient itself.

Depth of Wound Insights 

The minor burn segment is expected to witness a significant CAGR of 7.3% over the forecast period. According to the National Center for Injury Prevention and Control, 1.2 million people in the U.S. are affected by burn injuries annually. The segment is expected to exhibit steady growth over the forecast period. Treatment of minor burns includes traditional products such as gauze, tapes, and bandages. Advanced dressings are seldom used for treating minor burns. Chronic wounds include partial-thickness and full-thickness burns. These conditions take a longer time for healing and cover more than 15.0% of the body.

The partial-thickness burn segment is anticipated to exhibit the fastest growth over the forecast period. According to the U.S. FDA, approximately 40,000 people are hospitalized each year due to partial burns. The demand and usage of biologics such as skin grafts and advanced dressings for the treatment of partial burns are increasing, thereby boosting the growth of the segment. In addition, the availability of favorable reimbursement policies in developed countries for patients suffering from partial burns is likely to drive the segment over the forecast period.

Cause Insights

The thermal burns segment accounted for the largest revenue share of 75.2% in 2021 owing to a high incidence of fire-related burn injuries. According to American Burn Association (ABA), fire burns are responsible for 43.0% of the total burn admissions to burn centers. Scalding is caused by hot liquids or gases and most commonly occurs from exposure to high-temperature tap water in baths or showers, hot cooking oil, steam, and hot drinks. Children are particularly at risk of accidental burns.

The chemical burn segment is expected to witness the fastest growth over the forecast period. Chemical burns occur when the skin comes in contact with chemicals or their fumes and corrosive products, most probably acids. Chemicals or fumes diffuse into the skin and damage the underlying tissue without causing any apparent damage to the surface. Chemical burns occur immediately on contact. Prolonged exposure severely damages human tissues and leads to scarring. Acids damage cells by coagulating them, while bases liquefy cells. Alkalis cause more injury than acids and bases as they react with the lipids within a body.

End-use Insights

The hospitals segment accounted for the largest revenue share of 41.3% in 2021 owing to the increasing incidence of burn injuries and hospitalizations each year. According to NCBI, approximately 486,000 people are affected by burn injuries every year. According to the CDC, over 40,000 severely burned patients are hospitalized each year in the U.S. The rising incidence of burn injuries is expected to boost the market growth. Furthermore, hospitals provide advanced burn care products, which contribute to the overall growth of the hospitals segment. Hospitals also provide a large array of treatment options pertaining to burn care. Hospitals follow 504 DRG to provide quick reimbursements for burn-affected patients from the Medicare program. These factors are responsible for the growth of the segment.

Global burn care market share, by end-use, 2021 (%)

The others segment is expected to be the fastest-growing segment and is expected to witness a CAGR of 7.9% over the forecast period. The others segment includes home care and ambulatory care. Ambulatory burn care encompasses a wide array of clinical services for outpatients. It serves as a critical factor when patients affected by burns are transported or relocated to hospitals. In case of partial or full-thickness burns, the patient needs to be provided with immediate and proper care. This is provided with the help of ambulatory services. Government initiatives undertaken for improving healthcare expenditure and infrastructure are also aiding in the growth of the segment.

Regional Insights

North America dominated the burn care market and accounted for the largest revenue share of around 52.1% in 2021, owing to the increasing incidence of burns. According to a 2018 report by the American Burn Association, over 300 children are treated in emergency rooms in the United States each day, with roughly two children dying from burn injuries. In the U.S., children aged 16 and under account for roughly 26% of all burn center admissions. In addition, the National Center for Biotechnology Information (NCBI) estimates that 486,000 individuals are injured by fire each year. Thereby, burn care products are anticipated to be in high demand as a result of a high rate of burns.

Moreover, the presence of key market players in this region, focusing on strategic initiatives such as the launch of new products and mergers and acquisitions, is expected to create lucrative growth opportunities in the region. For instance, MiMedx Group Inc., in September 2020, introduced the EpiCord Expandable, a placental tissue allograft, to the market. This allograft's innovative design allows healthcare providers to cover up to twice the surface area and is intended to meet the needs of patients with larger, chronic, and difficult-to-heal wounds. As a result of the foregoing factors, the market in this region is expected to be one of the largest and grow in the future.

In Asia Pacific, the market is anticipated to witness the fastest CAGR of 8.6% over the forecast period. According to the WHO, the incidence of burn injuries that require immediate medical attention is approximately 20 times higher in the Western Pacific Region in comparison with the Americas. Moreover, each year, approximately 50,000 burns-related hospital admissions are recorded in Australia, with young children being particularly vulnerable. Scald burns (65%) and flame burns (20%) are the most common burn-related injuries among children aged four and under. Thus, an increase in the incidence of burn injuries is a major factor boosting the market in this region.

In addition, increasing R&D activities by key market players for the introduction of innovative products is expected to fuel the market growth over the forecast period. For instance, researchers at the University of South Australia, are developing stimuli-responsive dressings that securely reduce infection and stimulate healing. The team has developed an advanced silver nanoparticle hydrogel-coated dressing that might revolutionize burns treatments in children. Thus, the aforementioned factors are projected to drive the market in this region.

Key Companies & Market Share Insights

Key players are adopting various strategies such as mergers and acquisitions, product launches, partnerships, and geographical expansions to strengthen their foothold in the market. For instance, in May 2020, Integra LifeSciences announced a positive clinical result for Integra Bilayer Wound Matrix (IBWM). This product is part of the company’s regenerative technology portfolio that uses collagen and amniotic products. This was expected to help the company tap the innovative solution market and provide surgeons with repair and wound closure solutions. Some of the prominent players in the burn care market include:

  • 3M

  • Hollister Incorporated

  • Cardinal Health

  • Integra LifeSciences Corporation

  • Coloplast Corp.

  • DeRoyal Industries, Inc.

  • Smith & Nephew

  • ConvaTec Inc.

  • Mölnlycke Health Care AB.

  • Johnson & Johnson

Burn Care Market Report Scope

Report Attribute

Details

Market size value in 2022

USD 2.4 billion

Revenue forecast in 2030

USD 4.2 billion

Growth rate

CAGR of 7.1% from 2022 to 2030

Base year for estimation

2021

Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, depth of burn, cause, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

3M; Hollister Incorporated; Cardinal Health; Integra LifeSciences Corporation; Coloplast Corp.; DeRoyal Industries, Inc.; Smith & Nephew; ConvaTec Inc.; Mölnlycke Health Care AB; Johnson & Johnson

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Segments Covered in the Report 

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global burn care market report on the basis of product, depth of burn, cause, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Advanced dressing

      • Alginate Dressing

      • Collagen Dressing

      • Hydrogel Dressing

      • Hydrocolloid Dressings

      • Wound Contact Layers

      • Film Dressings

      • Foam Dressings

      • Others

    • Biologics

    • Traditional Burn Care Products

    • Others

  • Depth of Wound Outlook (Revenue, USD Million, 2018 - 2030)

    • Minor Burns

    • Partial Thickness Burns

    • Full Thickness Burns

  • Cause Outlook (Revenue, USD Million, 2018 - 2030)

    • Thermal Burns

    • Electrical Burns

    • Radiation Burns

    • Chemical Burns

    • Friction Burns

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)

    • Hospitals

    • Clinics

    • Others

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.